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Abstract
Introduction: In this report, we aimed to examine the stability of various analytes in saliva under different storage conditions.
Materials and methods: Alpha-amylase (AMY), cholinesterase (CHE), lipase (Lip), total esterase (TEA), creatine kinase (CK), aspartate aminotran-
sferase (AST), lactate dehydrogenase (LD), lactate (Lact), adenosine deaminase (ADA), Trolox equivalent antioxidant capacity (TEAC), ferric reducing 
ability (FRAS), cupric reducing antioxidant capacity (CUPRAC), uric acid (UA), catalase (CAT), advanced oxidation protein products (AOPP) and hydro-
gen peroxide (H2O2) were colorimetrically measured in saliva obtained by passive drool from 12 healthy voluntary donors at baseline and after 3, 6, 
24, 72 hours, 7 and 14 days at room temperature (RT) and 4 ºC, and after 14 days, 1, 3 and 6 months at – 20 ºC and – 80 ºC.
Results: At RT, changes appeared at 6 hours for TEA and H2O2; 24 hours for Lip, CK, ADA and CUPRAC; and 72 hours for LD, Lact, FRAS, UA and AOPP. 
At 4 ºC changes were observed after 6 hours for TEA and H2O2; 24 hours for Lip and CUPRAC; 72 hours for CK; and 7 days for LD, FRAS and UA. At – 20 
ºC changes appeared after 14 days for AST, Lip, CK and LD; and 3 months for TEA and H2O2. At – 80 ºC observed changes were after 3 months for TEA 
and H2O2. 
Conclusions: In short-term storage, the analytes were more stable at 4 ºC than at room temperature, whereas in long-term storage they were more 
stable at - 80 ºC than at – 20 ºC.
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Introduction
Interest in saliva assays for clinical purposes has in-
creased during recent years because this fluid has 
important advantages: its collection is easy, does 
not produce evident stress or pain and does not 
require expensive material or medical personnel. 
The main areas in which saliva can be used for 
testing are psychology and stress research, endo-
crinology, occupational and sports medicine, drug 
monitoring, metabolism and oxidative status eval-
uation, immunology and inflammation (1).  
The use of salivary biomarkers for diagnostic pur-
poses would be of benefit if standardised proce-
dures for saliva collection were used, as well as the 
validation/verification of the methods performed in 
saliva. In addition, knowledge of how the storage 
conditions can affect the stability of measured ana-
lytes is of major importance, especially as saliva is 
usually less stable than plasma (due to bacterial 
multiplication, viscosity or extensive proteolytic 
cleavage by endogenous and exogenous proteas-
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es) (2). Stability would be of particular importance 
when retrospective studies or studies involving 
multiple experimental sampling time-points are de-
signed, since they usually involve the storage of 
samples, and an inappropriate temperature can af-
fect enzymatic activities in saliva samples during 
sampling and storage (3).
Salivary α-amylase (AMY) increases in situations of 
acute stress and activation of the sympathetic 
nervous system (SNS), due to different psychologi-
cal causes or physical efforts (4). Changes in sali-
vary cholinesterase (CHE) activity have been de-
scribed in Alzheimer’s disease and they have been 
related to situations of stress, although it is tradi-
tionally measured as a biomarker of anti-CHE in-
secticides exposure (5,6). Salivary lipase (Lip) secre-
tion also seems to be promoted by the activation 
of the SNS (7). The total esterase activity (TEA) of 
saliva comprises several enzymatic activities, and 
it is increased in situations of physical stress (8). 
Creatine kinase (CK), aspartate transaminase (AST) 
and lactate dehydrogenase (LD) can increase in 
human saliva in conditions such as intensive exer-
cise (9). Lactate (Lact) is considered a marker of 
muscle function and its quantification in saliva is 
important in internal and sport medicine to moni-
tor the maximum performance level of athletes 
(10). Adenosine deaminase (ADA) is involved in 
various processes related with the immune sys-
tem, it is considered a biomarker of inflammation 
and it has been found to change in saliva in oral 
diseases (11). 
In situations of oxidative stress, reactive oxygen 
species (ROS) are produced in high amounts that 
cannot be removed by antioxidants. Total antioxi-
dant capacity (TAC) represents the antioxidant sta-
tus of a sample and comprises the sum of the con-
centrations of almost all non-enzymatic antioxi-
dants (12). It can be evaluated in saliva by different 
assays, such as ferric reducing ability of saliva 
(FRAS), cupric reducing antioxidant capacity (CU-
PRAC), and the 6-hydroxy-2,5,7,8-tetramethylchro-
man-2-carboxylic acid (Trolox) equivalent antioxi-
dant capacity (TEAC) (13). The Trolox equivalent 
antioxidant capacity, FRAS and CUPRAC are assays 
based on the ability of antioxidants present in a 
sample to reduce or inhibit oxidized products gen-
erated in the assay (14). The Trolox equivalent anti-
oxidant capacity measures the capacity of the 
sample to reduce the 2,2’-azino-bis(3-ethylbenz-
thiazoline-6-sulfonic acid) (ABTS) radical, whereas 
FRAS and CUPRAC measure the ability of a sample 
to reduce Fe3+ and Cu2+ to Fe2+ and Cu1+, respec-
tively. They have been evaluated in saliva in pa-
tients with diseases such as oral lichen planus (13). 
In addition, individual components of the antioxi-
dant system such as uric acid (UA) and catalase 
(CAT) can be measured. Uric acid is the final me-
tabolite of purines and represents approximately 
70% of salivary TAC (15). It can increase in hypoxia 
due to the appearance of oxidant metabolites and 
there is evidence that salivary UA is altered in dis-
eases such as oral lichen planus or diabetes (13,16). 
Catalase is an enzyme capable of removing ROS 
from saliva and its activity is altered in patients 
with different diseases such as human immunode-
ficiency virus (17). Components of the oxidant sys-
tem can also be measured in saliva, namely the ad-
vanced oxidation protein products (AOPP) and hy-
drogen peroxide (H2O2). Advanced oxidation pro-
tein products represent a sensitive biomarker of 
oxidative-modified proteins and it has been meas-
ured in human saliva before and after acute resist-
ance exercise (18). Hydrogen peroxide is a reactive 
species produced during normal metabolism, with 
increased concentrations found in situations of in-
flammation and tissue damage (19).
Studies on the stability for some of these analytes 
already have been published; such as stability of 
AMY at room temperature (RT), 4 ºC and after 
freeze-thaw cycle; stability of LD and AST at RT, 4 
ºC and – 20 °C for 3 months and at – 80 ºC for 28 
days, or the stability of AOPP for 4 weeks at – 20 ºC 
and – 80 ºC (2,3,20-25). However, long-term stud-
ies longer than 3 months in which different stor-
age conditions were compared have not been 
published. In addition, to the authors’ knowledge, 
there have not been studies about the stability of 
CHE, Lip, TEA, CK, Lact, ADA, TEAC, UA, CAT and 
H2O2 in human saliva under different conditions of 
storage.
Our hypothesis was that the analytes in saliva can 
have different changes depending of the sample 
storage conditions and used times. In this report, 
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we aimed to examine the stability of various ana-
lytes (AMY, CHE, Lip, TEA, CK, AST, LD, Lact, ADA, 
TEAC, FRAS, CUPRAC, UA, CAT, AOPP and H2O2) in 
saliva under different storage conditions.
Material and methods
Subjects
This experimental study was conducted at the In-
terdisciplinary Laboratory of Clinical Analyses of 
the University of Murcia, Spain, from June to De-
cember 2017. The experimental protocol was ap-
proved by the Investigation Ethics Committee of 
the University of Murcia (Spain) and followed the 
Declaration of Helsinki of the World Medical Asso-
ciation for research with humans.
Twelve subjects, six men (29-58 years) and six 
women (28-56 years) participated in this study. 
They were healthy volunteers from the personnel 
of Murcia University. All participants filled a ques-
tionnaire in which they were asked about habits, 
the presence and description of any acute or 
chronic disease, any type of symptom in the days 
before the experiment took place, or whether they 
were receiving or they had recently received any 
medical treatment. The inclusion criteria for the 
participants were that they should be adults with-
out any acute or chronic disease, not under physi-
cian’s care for any disease for the last 6 months, 
not receiving any medication (including hor-
mones, steroids or non-steroidal anti-inflammato-
ries), food supplements (vitamins or sport supple-
ments) and not being smokers or alcohol consum-
ers. In addition, subjects should not have oral dis-
eases, such as gingivitis or periodontitis, after 
complete examination of the oral cavity per-
formed by an oral medicine professional. 
Methods
The participants themselves performed sample 
collection. All participants received detailed infor-
mation by oral communication and written guide-
lines about the aims and experimental protocol, 
the saliva collection procedure, and signed written 
consent. They were informed about the need to 
avoid coughing or clearing the throat into the col-
lection tube and were to abstain from brushing 
teeth or using mouthwash, ingesting any food or 
chewing gum for 1 hour before saliva collection.
The participants rinsed their mouth with water 
five minutes before saliva collection. Then, unstim-
ulated saliva was collected by passive drool in the 
absence of chewing movements into 10 mL plain 
tubes (Proquilab, Murcia, Spain). Collection started 
in all subjects at 9:30 am and lasted between 2 
and 5 minutes. The volunteers sat in a relaxed po-
sition throughout the sampling procedure to 
avoid any stress. Between 3 to 5 mL of saliva was 
obtained from each participant, all samples were 
checked for blood contamination by visual inspec-
tion and no reddish samples indicating blood con-
tamination were included in the study. Immediate-
ly after collection, the saliva samples were centri-
fuged (Universal 320R, Hettich, Tuttlingen, Germa-
ny) at 5000xg and 4 ºC for 5 minutes, then the su-
pernatant was collected and divided into aliquots, 
discarding the sediment. To evaluate the effects of 
different storage conditions, 19 aliquots of each 
sample were prepared: (a) 1 aliquot was freshly an-
alysed (baseline) and used as the reference value 
for all analytes; (b) 4 aliquots of each sample were 
stored at room temperature (RT); (c) 6 aliquots 
were refrigerated at 4 ºC, (d) 4 were frozen at – 20 
ºC and (e) 4 were frozen at – 80 ºC. The aliquots 
stored at RT were analysed at 3 (T1), 6 (T2), 24 (T3) 
and 72 (T4) hours after sampling; the refrigerated 
aliquots were analysed at T1, T2, T3 and T4, and in 
addition 7 (T5) and 14 days (T6) from collection. Fi-
nally, the aliquots stored at – 20 ºC and at – 80 ºC 
were analysed 14 days (T6), 1 (T7), 3 (T8) and 6 
months (T9) from collection.
The analytical methods used, which were adapted 
in the authors’ laboratory for saliva samples, as 
well as their fundamentals, details of the reagents 
and analytical performance, appear in Table 1. All 
assays were performed on an automated bio-
chemistry analyser (Olympus AU400, Olympus Di-
agnostica GmbH, Ennis, Ireland) at 37 ºC. Manufac-
turers’ control solutions of two different values 
were used for the quality control analysis of AMY, 
Lip, CK, AST, LD, Lact and UA (Beckman Coulter, lot 
0037 and 0038) and one control solution was used 
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for ADA (Diazyme, DZ177A-Con). Daily in-house 
controls of two different values were used for anal-
ysis of FRAS, TEAC, CUPRAC, CAT, AOPP and H2O2. 
The control for FRAS was a ferric chloride hexahy-
drate solution, for TEAC and CUPRAC a Trolox solu-
tion, an enzyme solution for CAT, Chloramine-T so-
lution for AOPP, and a H2O2 solution for H2O2 assay. 
A single measurement was made in all cases since 
all analytical methods showed an intra-assay im-
precision lower than 15%, which indicated ade-
quate assay repeatability.
Statistical analysis
Descriptive statistical procedures and spread-
sheets (Excel 2000, Microsoft Corporation, Red-
mond, USA) and software (Graph Pad Prism, Ver-
sion 5 for Windows, Graph Pad Software Inc, San 
Diego, USA, and IBM SPSS statistic for Windows, 
version 24.0, IBM Corp., Armonk, USA) were used. 
Since only 12 data were included, normality was 
not assumed. Therefore, the values of the analytes 
at different times and conditions after storage 
were compared with aliquots analysed immedi-
ately using the Friedman test, followed by Dunn’s 
multiple comparison test. The results were consid-
ered significant when P < 0.05.
Results
The results for the stability of the studied analytes, 
under different storage conditions, are shown in 
Table 2. 
At RT, AMY, CHE, AST, TEAC and CAT were stable 
during the whole experimental period (72 hours). 
The analytes that showed significant decreases 
were: TEA at 6 hours; Lip, CK and CUPRAC at 24 
hours; and LD, Lact, FRAS, UA and AOPP at 72 
hours. Significant increases were detected for 
H2O2 at 6 hours and for ADA at 24 hours.
At 4 ºC, AMY, CHE, AST, Lact, ADA, TEAC, CAT and 
AOPP were stable after 14 days of storage. Signifi-
cant decreases were observed after 6 hours for 
TEA; after 24 hours for Lip and CUPRAC; after 72 
hours for CK; and after 7 days for LD, FRAS and UA. 
Significant increases were recorded for H2O2 after 
6 hours. 
When samples were stored at - 20 ºC, AMY, CHE, 
Lact, ADA, TEAC, FRAS, CUPRAC, UA, CAT and 
AOPP were stable for 6 months. Significant de-
creases were recorded after 14 days of storage for 
AST, Lip, CK and LD; and after 3 months for TEA. A 
significant increase was observed for H2O2 after 3 
months of storage. 
At - 80 ºC, AMY, CHE, AST, Lip, CK, LD, Lact, ADA, 
TEAC, FRAS, CUPRAC, UA, CAT and AOPP were sta-
ble for 6 months. Significant decreases were ob-
served after 3 months for TEA. A significant in-
crease was detected for H2O2 at 3 months.
Discussion 
This study found that although there was a varia-
bility in the results depending on the studied ana-
lyte, in general, in the short-term storage condi-
tions tested, the storage at 4º C provided longer 
stability for analytes in saliva than at RT. On the 
other hand, in the long-term storage conditions 
tested, - 80º C provided longer stability than - 20º 
C. In the short-term storage conditions, we also in-
cluded storage for 72 hours at RT and 7 days at 4º 
C. We are aware that samples are not usually 
stored in these conditions; however, other re-
searchers in their stability studies have used simi-
lar time points and they were included in our 
study in order to obtain information regarding sta-
bility in those conditions (26). 
Regarding individual analytes, AMY, CHE and ADA 
were the enzymes that showed fewer changes in 
the different storage conditions. The high stability 
of AMY is in accordance with the results of other 
studies where, for example, AMY was stable for 5 
days at RT or for 10 days at RT or 4 ºC (20,21). Cho-
linesterase was also stable in all conditions, so it 
seems that its activity is not affected after storage, 
although there is a lack of previous reports to 
compare with. Adenosine deaminase was also sta-
ble in most of the conditions with the exception of 
RT, where it showed a significant increase. Stability 
of ADA has been studied in porcine saliva and was 
considered as stable for up to 1 year at - 80 ºC (27). 
The reason why the activity of this enzyme in sali-
va increases at RT needs to be further elucidated.
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Lipase and CK showed a high stability at - 80 ºC; 
however, in the rest of the storage conditions they 
showed significant changes. To our knowledge, 
the stability of Lip and CK in saliva under different 
storage conditions has not been accessed before, 
and the reason for lipase and CK enzymatic activi-
ty changes in saliva is unknown and should be fur-
ther studied. Aspartate aminotransferase showed 
also the highest stability at - 80 ºC, being stable for 
6 months. The lack of stability of AST in other stor-
age conditions, such as - 20 ºC, agrees with previ-
ous reports (2,3). 
Total esterase and LD were the most labile en-
zymes in our stability study. It is difficult to know 
the reason for the changes of TEA, it is likely to 
have been influenced by the instability of any of 
the various enzymes that integrate in this total ac-
tivity (8). Lactate dehydrogenase results in our 
study were similar to other reports that showed a 
significant decrease of this enzyme in saliva after 
only 30 min, 3 days  and 2 weeks of storage at - 20 
ºC (2,3,22). These results could be due to the labili-
ty of the LD-4 and LD-5 isoenzymes at - 20 ºC (28).
With the exception of H2O2, the remaining antioxi-
dants biomarkers showed a high stability under 
freezing conditions. Uric acid has been observed 
to remain relatively stable during storage, in ac-
cordance with previous studies describing stability 
at - 20 ºC, - 70 ºC and at - 196 ºC in human serum 
when stored for 1 year (29). This can also help to 
explain the stability observed for the TEAC and 
FRAS in saliva, both at - 20 ºC and at - 80 ºC, as UA 
is one of the main contributors to TEAC and FRAS. 
When oxidant biomarkers were studied, AOPP 
showed a high level of stability in all conditions, 
except at RT. Only H2O2 was very unstable and 
could only be measured after 3 hours at 4 ºC or 1 
month under freezing conditions. Further studies 
should be made to elucidate the reason for the 
production of H2O2 in the saliva samples when 
they are stored.
This study has some limitations that should be tak-
en into account. Firstly, the study has been made 
in healthy subjects. It would be of interest in the 
future to perform further studies also involving 
subjects with different diseases in order to evalu-
ate the possible differences of stability between 
samples of healthy and sick subjects. Although in 
line with previous reports, the number of subjects 
included in this study can be considered low and 
ideally a higher number of cases should be includ-
ed (21,25,30). Therefore, this report should be tak-
en as a pilot study and additional studies would be 
needed prior to making recommendations about 
the storage conditions. In addition, in the case of 
the enzymes, it would have been interesting to 
study the stability of the different isoenzymes.  
It can be concluded that in short-term storage the 
analytes were more stable at 4 ºC than at room 
temperature, whereas in long-term storage they 
were more stable at - 80 ºC than at - 20 ºC.
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